A hospital-wide intervention replacing ceftriaxone with cefotaxime to reduce rate of healthcare-associated infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the intensive care unit

Intensive Care Med. 2018 May;44(5):672-673. doi: 10.1007/s00134-018-5079-y. Epub 2018 Feb 2.

Boun Kim Tan¹, Emmanuel Vivier², Karim Ait Bouziad³, Jean-Ralph Zahar^{4

5}, Christian Pommier², Laurence Parmeland⁶, Caroline Pariset⁷, Pauline Misslin⁸, Catherine Haond⁹, Philippe Poirié¹⁰, Laura Temime^{3

11}, Mounia N Hocine^{3

11}

¹ Intensive Care Unit, Saint Joseph-Saint Luc Hospital, 20 quai Claude Bernard, 69007, Lyon, France. tanbounkim@yahoo.fr.
² Intensive Care Unit, Saint Joseph-Saint Luc Hospital, 20 quai Claude Bernard, 69007, Lyon, France.
³ MESuRS Laboratory, Conservatoire National des Arts et Métiers, Paris, France.
⁴ Microbiology and Infection Control Department, Avicenne Academic Hospital, Assistance Publique des Hôpitaux de Paris, Bobigny, France.
⁵ IMEA, Paris-Nord University, Bobigny, France.
⁶ Biology Department, Saint Joseph-Saint Luc Hospital, Lyon, France.
⁷ Infectious Diseases Unit, Saint Joseph-Saint Luc Hospital, Lyon, France.
⁸ Pharmacy Department, Saint Joseph-Saint Luc Hospital, Lyon, France.
⁹ Hospital Hygiene and Infection Control Department, Edouard Herriot Academic Hospital, Hospices Civils de Lyon, Lyon, France.
¹⁰ Medical Information Department, Saint Joseph-Saint Luc Hospital, Lyon, France.
¹¹ PACRI Unit, Institut Pasteur, Conservatoire National des Arts et Métiers, Paris, France.

No abstract available

Publication types